vimarsana.com

Page 25 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Approves Hepzato Kit for Metastatic Uveal Melanoma

The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.

Vojislav vukovicAccess programDrug administrationNational comprehensive cancer networkHepzato kitDelcath systemsExpanded access programRisk evaluationMitigation strategyUveal melanoma

Delcath Systems Stock Soars 90% In One Session - Here s Why - Delcath Systems (NASDAQ:DCTH)

The FDA approved Delcath Systems Inc's (NASDAQ: DCTH) HEPZATO KIT (melphalan/Hepatic Delivery System). 

Delcath systems incAccess programHepatic delivery systemExpanded access programPublic equity

Seelos Therapeutics Provides Second Quarter 2023 Clinical Update

- Seelos expects to release top-line data in its registration directed study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation .

United statesNew yorkAnthony marcianoMike moyerLos angelesLifesci advisorsHarvard medical school at massachusettsSociety for neuroscienceNasdaq hearings panelPrnewswire seelos therapeutics incSeelos therapeutics incAccess programNasdaq stock marketExchange commissionAmerican society of geneNational institute of neurological disorders

Clarity s theranostic prostate cancer trial advances to highest dose level

Highlights Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been.

New south walesUnited statesAlan taylorLuke nordquistSafety review committeeTechnology platformUrology cancer center xcancer omahaClarity pharmaceuticalsAmerican cancer instituteDrug administrationPrnewswire clarity pharmaceuticalsAccess programProstate specific antigenUnited states foodExpanded access programProstate specific membrane antigen

Clarity s theranostic prostate cancer trial advances to highest dose level

Clarity s theranostic prostate cancer trial advances to highest dose level
sydneysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sydneysun.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesLuke nordquistAlan taylorUrology cancer center xcancer omahaTechnology platformSafety review committeePrnewswire clarity pharmaceuticalsAccess programClarity pharmaceuticalsAmerican cancer instituteDrug administrationProstate specific antigenUnited states foodExpanded access programProstate specific membrane antigen

vimarsana © 2020. All Rights Reserved.